Lowell Hart to Angiogenesis Inhibitors
This is a "connection" page, showing publications Lowell Hart has written about Angiogenesis Inhibitors.
Connection Strength
0.024
-
Herbst RS, Ansari R, Bustin F, Flynn P, Hart L, Otterson GA, Vlahovic G, Soh CH, O'Connor P, Hainsworth J. Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial. Lancet. 2011 May 28; 377(9780):1846-54.
Score: 0.024